DNAPRINT BUYS STAKE IN GERMAN DRUG FIRM

DNAPrint genomics Inc. said it has bought an 18 percent stake in Biofrontera AG, a German pharmaceutical firm, for 1.5 million euros. That's about $1.84 million based on current exchange rates. DNAPrint bought its interest from Technologie-Beteiligungs-Gesellschaft mbH, an instrumentality of the German government, according to a July 13 filing with the Securities and Exchange Commission.

Tampa Bay Business Journal (http://tampabay.bizjournals.com/tampabay/stories/2005/07/11/daily42.html)